Research progress of hydroxychloroquine and autophagy inhibitors on cancer

Abstract

Hydroxychloroquine (HCQ), the analog of chloroquine, augments the effect of chemotherapies and radiotherapy on various tumors identified in the current clinical trials. Meanwhile, the toxicity of HCQ retinopathy raises concern worldwide. Thus, the potent autophagy inhibitors are urgently needed. A systematic review was related to ‘hydroxychloroquine’ or… (More)
DOI: 10.1007/s00280-016-3197-1

Topics

2 Figures and Tables

Cite this paper

@article{Shi2016ResearchPO, title={Research progress of hydroxychloroquine and autophagy inhibitors on cancer}, author={Ting-Ting Shi and Xiao-Xu Yu and Li-jun Yan and Hongtao Xiao}, journal={Cancer Chemotherapy and Pharmacology}, year={2016}, volume={79}, pages={287-294} }